Opinion

Jan 15, 2025, 13:47

5 Articles suggested by Wafik El-Deiry

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.

Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.

Wafik El-Deiry

Wafik El-Deiry shared a few must-reads paper on X:

Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer

Authors: Jason M. Link et al.

5 Articles suggested by Wafik El-Deiry

Reinventing type 2 immunity in cancer

Authors: Marek Wagner et al.

5 Articles suggested by Wafik El-Deiry

KRAS^G12D drives immunosuppression in lung adenocarcinoma through paracrine signaling

Authors: Emily L. Lasse-Opsahl et al.

5 Articles suggested by Wafik El-Deiry

A vision–language foundation model for precision oncology

Authors: Jinxi Xiang et al.

5 Articles suggested by Wafik El-Deiry

Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials

Authors: Jia Liu et al.

Adel Kardosh Alex Guimaraes Alison Grossblatt-Wait Allison L. Creason Andrew C. Adey Brett C. Sheppard Brian Brinkerhoff cancer Carl Pelz Carlos E. Espinoza Charles D. Lopez Colin Bergstrom Craig J. Galban David Kilburn Dove J. Keith Ellen M. Langer Elmar Bucher Elyse McLintock Emek Demir Emily L. Lasse Opsahl Feyisope Eweje Francesca Maria Olguin Gordon B. Mills Gustavo Salgado-Garza Hannah Holly Hiroyoshi Nishikawa Isabel A. English Ivana Barravecchia Jason M. Link Jeffrey J. Nirschl Jennifer M. Lee Jennifer R. Eng Jeremy Goecks Jinxi Xiang Joel Neal Jonathan R. Brody Julian Egger Kevin MacPherson-Hawthorne Koei Chin Konjit Betre Kristee Brown Kristena Y. Abdelmalak Kun-Hsing Yu Lily Rober Lisa M. Coussens Marek Wagner Marina Pasca di Magliano Marzia Robotti Matthew Gopaulchan Maximilian Diehn Michael B. Heskett Michael W. Munks Motoyuki Tsuda Nell Kirchberger OncoDaily Oncology Patrick J. Worth Rachael Hinshaw Rosalie C. Sears Ruijiang Li Sara Protzek Sarah F. Ferris Sen Yang Shamaline Sivagnanam Shigeo Koyasu Sierra Willens Sophia Cavanaugh Stefanie Galban Sydney Owen Ted Kim Terry K. Morgan Timothy L. Frankel Wafik El-Deiry Xiaoming Zhang Xiyue Wang Yaqing Zhang Yijiang Chen Yinghua Xi Yuchen Li Zhi Hu

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage